Loading clinical trials…
Loading clinical trials…
Clinical trials · failure tracking
Oncology studies whose overall status is TERMINATED, WITHDRAWN or SUSPENDED on ClinicalTrials.gov, with the stop reason exactly as the registrant posted it. A category is attached only when an explicit keyword rule matches the text; CancerIndex never infers why a study stopped.
3 stopped studies mapped to Myelodysplastic Syndrome/Acute Myeloid Leukemia and descendants · 100% state a reason
Over the 3 studies matching the cancer, status and year filters (the category filter does not change this chart). Each study is counted once, in the first matching category; greyed bars are studies whose text matched no rule or was empty.
Computedrules ci-stop-reasons-v1 · keyword matching only
A category is assigned when one of its keywords appears in the posted text (case-insensitive, whole words). Rules are tested in this order and the first match wins; every match is kept in the API (reasonMatches).
| NCT | Title | Phase | Status | First posted | Lead sponsor | Why stopped (as posted) | Category |
|---|---|---|---|---|---|---|---|
| NCT06454409 | Regorafenib in Combination With Venetoclax and Azacitidine for the Treatment of Patients… | Phase 1 | suspended | Jun 12, 2024 | City of Hope Medical Center | resources | Other (stated, no rule matched) |
| NCT04526288 | CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade… | Phase 2 | terminated | Aug 25, 2020 | Fred Hutchinson Cancer Center | Terminated due to low accrual | Enrollment / accrual |
| NCT04361058 | Nivolumab for High-Risk MDS/AML Patients After Allogeneic Stem Cell Transplant With… | Phase 1 | withdrawn | Apr 24, 2020 | SCRI Development Innovations, LLC | The single site that was deemed appropriate for this study was unable to enroll patients. Closed… | Enrollment / accrual |
Stop reasons are registrant-reported free text and are displayed verbatim (truncated; hover for the full text). Categories come from explicit keyword rules and are never inferred from the study design, sponsor or outcome; a study that stopped for several reasons is filed under the first rule that matched. A TERMINATED status does not imply a negative result.
Data updated 22 days agoSource updated Nov 19, 2025source: clinicaltrials